ChromoSeq, an advanced diagnostic assay developed in the Department of Pathology & Immunology at Washington University School of Medicine in St. Louis, was recently approved for reimbursement by The Centers for Medicare & Medicaid Services (CMS), a milestone for test developers and a win for patients with myeloid malignancies. The test is based on whole […]
ChromoSeq now covered by Medicare















































